AETOSWire - AETOSWire
العربية
Toggle navigation
Home
About us
About
Partners
Blog
Services
News Distribution
Financial Disclosure
Online Presskit
Interpretation
Content Services
Translation
Copywriting
Editing
Proofreading
Transcribing
Newsroom
All Press Releases
Multimedia Newsroom
Contact
Account
العربية
Login
Register
العربية
Toggle navigation
Home
About us
About
Partners
Blog
Services
News Distribution
Financial Disclosure
Online Presskit
Interpretation
Content Services
Translation
Copywriting
Editing
Proofreading
Transcribing
Newsroom
All Press Releases
Multimedia Newsroom
Contact
Account
العربية
Login
Register
NewsRoom
Home
NewsRoom
Organon & Co.
Newsroom
Multimedia Newsroom
Tuesday, 27. May 2025
US Food and Drug Administration (FDA) Grants Interchangeability Designation to...
Read More
Friday, 28. March 2025
European Medicines Agency (EMA) Validates Henlius and Organon Filing for...
Read More
Wednesday, 30. October 2024
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar...
Read More
Monday, 28. October 2024
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA®...
Read More
Monday, 30. September 2024
Primary Endpoint Met in Phase 3 Comparative Clinical Study of...
Read More
Wednesday, 18. September 2024
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA®...
Read More
Tuesday, 20. August 2024
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional...
Read More
Friday, 24. May 2024
European Medicines Agency (EMA) Validates Henlius and Organon Filings for...
Read More
Monday, 08. April 2024
Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab)...
Read More
Monday, 18. December 2023
Organon & Lilly Enter Commercialization Agreement in Europe for Two...
Read More
Wednesday, 27. September 2023
Organon Recognized on Fortune’s 2023 Change the World List for...
Read More
Tuesday, 05. September 2023
Organon Bolsters Research & Development Expertise with Two Leadership Appointments
Read More
‹
1
2
›
Your experience on this site will be improved by allowing cookies.
Cookie Policy
Allow cookies
Search...
Search...